TerraBioGen Raises New Funds Through Private Placement

VANCOUVER, BRITISH COLUMBIA--(Marketwire - Feb. 7, 2012) -

THIS PRESS RELEASE, REQUIRED BY APPLICABLE CANADIAN LAWS, IS NOT FOR DISTRIBUTION TO U.S. NEWS SERVICES OR FOR DISSEMINATION IN THE UNITED STATES

TerraBioGen Technologies Inc. (TSX VENTURE:TBG), a developer and marketer of proprietary technologies for the production of organic-based, high-value agricultural products from organic wastes, announces that it has raised additional funding of $750,000 through a non-brokered private placement of 7,500,000 commons shares at $0.10 per share. The transaction is subject to the approval of the TSX Venture Exchange. These funds will be used to enhance the Company's research and development, securing its intellectual property, and for production improvements.

The Company also announces that it has cancelled the balance of a previous $1.5 million private placement. The first tranche of that non-brokered private placement was closed in December 2011 with the issuance of 10,000,000 shares at a price of $0.10 per share for gross proceeds of $1,000,000 and 5,000,000 warrants exercisable at $0.15 up to June 9, 2013.

The Company further announces that it has cancelled a Master License Agreement ("MLA") for the Middle East. Under the terms of the MLA, the licensee was required to pay scheduled license fees but they were unable to make the required payments.

About TerraBioGen

Located in North Vancouver, BC, TerraBioGen Technologies Inc. is committed to research and development to continue to improve the efficiency of its technology and the quality of its agricultural products. It is further committed to developing a world-wide marketing capability to ensure market acceptance of its products.

This news release contains certain statements that may be deemed "forward-looking" statements. Forward looking statements are statements that are not historical facts and are generally, but not always, identified by the words "expects", "plans", "anticipates", "believes", "intends", "estimates", "projects", "potential" and similar expressions, or that events or conditions "will", "would", "may", "could" or "should" occur. Although TerraBioGen believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results may differ materially from those in forward looking statements. Forward looking statements are based on the beliefs, estimates and opinions of TerraBioGen's management on the date the statements are made. Except as required by law, TerraBioGen undertakes no obligation to update these forward-looking statements in the event that management's beliefs, estimates or opinions, or other factors, should change.

THIS PRESS RELEASE, REQUIRED BY APPLICABLE CANADIAN LAWS, IS NOT FOR DISTRIBUTION TO U.S. NEWS SERVICES OR FOR DISSEMINATION IN THE UNITED STATES, AND DOES NOT CONSTITUTE AN OFFER OF THE SECURITIES DESCRIBED HEREIN. THESE SECURITIES HAVE NOT BEEN REGISTERED UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED, OR ANY STATE SECURITIES LAWS, AND MAY NOT BE OFFERED OR SOLD IN THE UNITED STATES OR TO U.S. PERSONS UNLESS REGISTERED OR EXEMPT THEREFROM.